Page last updated: 2024-10-26

erythrosine and Frontotemporal Lobar Degeneration

erythrosine has been researched along with Frontotemporal Lobar Degeneration in 1 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Frontotemporal Lobar Degeneration: Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ng, JSW1
Hanspal, MA1
Matharu, NS1
Barros, TP1
Esbjörner, EK1
Wilson, MR1
Yerbury, JJ1
Dobson, CM1
Kumita, JR1

Other Studies

1 other study available for erythrosine and Frontotemporal Lobar Degeneration

ArticleYear
Using Tetracysteine-Tagged TDP-43 with a Biarsenical Dye To Monitor Real-Time Trafficking in a Cell Model of Amyotrophic Lateral Sclerosis.
    Biochemistry, 2019, 10-01, Volume: 58, Issue:39

    Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Cell Line, Tumor; Cell Nucleus; Cysteine; Cytoso

2019